Patent 8071632 was granted and assigned to Reata Pharmaceuticals, Inc. on December, 2011 by the United States Patent and Trademark Office.
Disclosed herein are novel oleanolic acid derivatives. Methods of preparing these compounds are also disclosed. The oleanolic acid derivatives of this invention may be used for the treatment and prevention of many diseases, including cancer, neurological disorders, inflammation, and pathologies involving oxidative stress.